Now Reading: Three IPOs close today: Hy-Tech, Symbiotec, Skyways set strong subscription
-
01
Three IPOs close today: Hy-Tech, Symbiotec, Skyways set strong subscription
Three IPOs close today: Hy-Tech, Symbiotec, Skyways set strong subscription
Three initial public offerings, Hy-Tech Engineers, Symbiotec Pharmalab and Skyways Air Services, closed for subscription on Thursday, each seeing strong demand. Hy-Tech Engineers led the pack with 114.06 times subscription by 12.30 pm, followed by Skyways Air Services at 14.40 times and Symbiotec Pharmalab at 13.86 times, according to exchange data. The price bands were ₹50-53 for Hy-Tech, ₹938-988 for Symbiotec and ₹131-138 for Skyways.
Hy-Tech Engineers is raising ₹135.73 crore through its IPO, with proceeds planned for machinery procurement, debt repayment and expansion at three units. Skyways Air Services aims to raise ₹174.5 crore from anchor investors, using funds for borrowing repayment and working capital. Symbiotec Pharmalab's issue includes a fresh component of ₹150 crore and an offer-for-sale worth ₹1,607 crore, with the Indore-based company using proceeds for debt payment.
Hy-Tech Engineers shares are scheduled to list on the BSE and NSE on September 1.
Indian Opinion Analysis
Both outlets report the same subscription numbers in near-identical language, confirming a straight news event on which there is no interpretive disagreement. The framing is uniform: demand itself is the story, with no editorialising about market mood or investor behaviour. The implication is straightforward: none of the three IPOs struggled to attract bids, and Hy-Tech Engineers saw exceptional retail and NII interest. The next concrete event is the listing on the BSE and NSE on 1 September, which will test whether the high subscription translates into the gains implied by grey market premiums.
Coverage: 2 sources, 2 neutral
Sources (2): ndtvprofit.com (neutral report), thehindubusinessline.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.
Updated: this story now draws on 2 sources.
